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Abstract—Gelatin is a natural polymer used in pharmaceutical and medical applications, especially
in the production of biocompatible and biodegradable wound dressings and drug delivery systems.
Gelatin granules hydrate, swell and solubilize in water, and rapidly degrade in vivo. The durability
of these materials could, however, be prolonged by cross-linking by aldehydes, carbodiimides, and
aldose sugars, but the biocompatibility of collagenous biomaterials is profoundly in uenced by the
nature and extent of cross-linking. In this study, gelatin sponges were prepared by using various cross-
linkers such as glutaraldehyde(GA), 1-ethyl-3-(3-dimethylaminopropyl)-carbodiimidehydrochloride
(EDAC), and D-fructose. The effects of the type and the amount of cross-linker on thermal and
mechanical properties, stability, and cytotoxicity were investigated. The mechanical analysis data
showed that an increase in the amount of GA in the sponge structures caused a slight increase in
the modulus of elasticity but had almost no effect on the tensile strength. Increase in the EDAC
concentration produced a maximum in the modulus of elasticity and tensile strength values. The
stability of the sponges and the time required for complete degradation in aqueous media increased in
parallel with the cross-linker content. In vitro studies carried out with  broblast cells demonstrated a
higher cell viability for the samples cross-linked with low concentrations of GA than for those cross-
linked with EDAC.
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solubility; degradation.
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INTRODUCTION
Gelatin, the major constituent of skin, bone, and connective tissues, is generally ob-
tained from collagen by controlled hydrolysis. The biological origin and biocom-
patibility of gelatin has led to wide-ranging applications in the pharmaceutical and
medical  elds; for example, as sealants for vascular prostheses [1, 2], bone-repairing
matrices, controlled drug release systems [3–5], ligament substitutes, wound dress-
ing materials [6–8], wound healing agents [9, 10], and scaffolds for tissue engineer-
ing purposes [11].
Gelatin granules,  lms, and sponges quickly hydrate in aqueous media and rapidly
degrade in vivo. Cross-linking the structure can improve the mechanical properties,
increase stability, and prolong durability. A number of cross-linking methods
have been described, such as treatment with heat [12], or ultraviolet or gamma
irradiation [13, 14], and by adding chemical agents such as sugar [15], epoxy
compounds [16, 17], formaldehyde [18], glutaraldehyde [19, 20], genipin [21], and
carbodiimides [2, 22, 23]. However, it must be remembered that the use of cross-
linkers can lead to toxic side-effects due to the unreacted residues.
Glutaraldehyde (GA) is the most commonly used cross-linking reagent in the
preparation of bioprostheses (such as heart valves, vascular grafts, elastic cartilage,
and arti cial skin), in cell and enzyme immobilization, and in protein and polysac-
charide stabilization. GA is presumed to cross-link by inter- and intramolecular
covalent bonds. This can occur in two ways: by the formation of a Schiff base by
the reaction of the aldehyde group with the amino group of lysine or hydroxylysine
(Fig. 1A), or by aldol condensation between two adjacent aldehydes. The Schiff
base linkage is not very stable, whereas the aldol condensation product is. GA not
only interacts with amino groups, but can also react with carboxy, amido, and other
groups of proteins. GA cross-linking of collagenous tissues signi cantly reduces
biodegradation, making them biocompatible and non-thrombogenic while preserv-
ing anatomic integrity, strength, and  exibility. Among aldehydes, which are used
to cross-link a protein matrix, GA is advantageous because its reaction is rapid; it is
less expensive; it is readily available and highly soluble in aqueous solution; and it
reacts with a large number of available amino groups present in proteins. The poly-
merization of GA takes place quickly under alkaline conditions, but even at pH 5,
aqueous solutions of GA contain polymeric moieties. Compared with formaldehyde
and other aldehydes, the cross-links are more stable when GA reacts with proteins
such as albumin, collagen, and mucopolysaccharides including heparin [24].
Carbodiimides belong to the class of zero-length cross-linkers, in contrast to
bifunctional reagents such as GA or polyfunctional reagents such as polyepox-
ides. Carbodiimides activate the carboxylic acid groups of glutamic or aspartic
acid residues and form bonds with the amino groups of another polypeptide chain
(Fig. 1B), but they do not remain in the linkage and are released as substituted
urea molecules [2]. They are available in a variety of molecular structures and the
most widely used is 1-ethyl-3-(3-dimethylaminopropyl)-carbodiimide hydrochlo-
ride (EDAC).
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Figure 1. Schematic presentationof gelatin cross-linkagewith (A) glutaraldehyde, (B) carbodiimide,
and (C) fructose.
1206 K. Ulubayram et al.
Glucose or other aldose sugars may provide another possibility for gelatin cross-
linking by one or several reactions. One possible mechanism involves aldose sugars.
In this case, the aldehyde group of the reducing sugar (e.g. glucose or fructose) can
react with the free amino group of the gelatin molecule to form aminoglycoside,
which can react further with another amine group, leading to a cross-linked network
structure (Fig. 1C).
The most important requirement for the clinical usefulness of cross-linked gelatin
or collagen is their non-toxic properties. It is known that gelatin itself is not toxic,
but the cross-linkers used for the preparation of stable structures may create toxicity.
In the literature, it has been reported that GA-related molecules could be released
from cross-linked collagen-based biomaterials and lead to toxicity [25, 26]. The
released molecules may be either unreacted GA present in the sample or products
of hydrolytic or enzymatic degradation of collagen [27], and may contribute to the
toxicity observed in vivo and in vitro [28, 29]. It was reported that materials cross-
linked with GA at concentrations higher than 0.05% (v/v) are highly cytotoxic
[28]. It was also reported that a GA concentration of 3.0 ppm released upon
biodegradation is toxic [30]. Other cross-linkers such as genipin, epoxy compounds,
carbodiimides, and sugars have been evaluated in an attempt to eliminate the
cytotoxicity associated with the use of aldehydes and they were reported to be
signi cantly less cytotoxic than GA [31–33]. EDAC is known as a non-toxic
and biocompatible cross-linker, since it is not incorporated into the cross-linked
structure, but is simply transformed into a water-soluble urea derivative during the
production process. The cytotoxicity of urea derivatives has been found to be quite
low compared with EDAC and in the literature, EDAC-crosslinked collagen has
been reported to be biocompatible in both in vitro and in vivo studies [34–36]. It
was reported that sugar moieties did not lead to inhibition of cell growth in vitro
assays [37].
In this study, gelatin matrices were prepared in sponge form by using various
cross-linkers. The physical and mechanical properties of the prepared matrices were
examined and cytotoxicity experiments were carried out in vitro in order to study
the cell viability of  broblast cells.
MATERIALS AND METHODS
Materials
Bacto gelatin was purchased from Difco Laboratories (USA). 1-Ethyl-3-(3-di-
methylaminopropyl)-carbodiimide hydrochloride (EDAC), D-fructose, 10% calf
serum, and Dulbecco’s modi ed eagles medium F12 (DMEM-F12) were obtained
from Sigma Chemical Co. (St Louis, MO, USA). Glutaraldehyde was from
BHD Limited (Poole, UK). Giemsa was from Merck (Germany). The human
skin  broblast cell line (HSAn2) was kindly supplied by HUKUK FMD Institute
(Ankara, Turkey). All other reagents were of analytical grade.
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Table 1.
Densities of the gelatin sponges (n D 9)
Sample Type of cross-linker Amount of cross-linker Cross-linker (mmol) Density (g/ cm3)
GS — — — 0:0070 § 0:0004
GS-GA1 GA 5 ml of 0.5% (v/v) 0.25 0:0064 § 0:0004
GS-GA3 GA 1 ml of 5% (v/v) 0.50 0:0081 § 0:0015
GS-EDAC1 EDAC 1 ml of 0.5% (w/v) 0.026 0:0062 § 0:0011
GS-EDAC4 EDAC 1 ml of 5% (w/v) 0.26 0:0060 § 0:0004
GS-EDAC6 EDAC 5 ml of 5% (w/v) 1.30 0:0076 § 0:0008
GS-F Fructose 0.075 g 0.42 0:0077 § 0:0009
Preparation of gelatin sponges
Aqueous gelatin solutions (3% w/v, 50 ml) were heated to 60±C and cross-linking
agents were added to the solutions under continuous stirring at 2000 rpm for 30 min.
Foaming solutions were poured into Petri dishes (1.5 cm thick) and freeze-dried
[6, 38]. The compositions of the prepared sponges are given in Table 1.
Density analysis
The prepared sponges were cut into cubes (ca 1 cm on each side) with extreme
care, the dimensions were carefully measured with a micrometer, and the sponges
weighed. Sponge densities were calculated from the mass to volume ratio. At least
nine measurements of each type of sponge were made and averages were calculated.
Mechanical analysis
The mechanical properties of the gelatin sponges were investigated by using a
Lloyd® mechanical testing machine (Lloyd Instruments, LRX) at 23 § 2±C. For
this purpose, rectangular prism sponge samples (approximately 20 mm £ 50 mm £
10 mm) were placed on the  xed and movable member of the mechanical testing
machine by special clamps. The applied extension rate was 2 mm/min. For each
type of sponge, at least nine samples were subjected to tensile testing. One-way
ANOVA was applied to determine the average, the standard deviation, and the
signi cance of the difference.
Thermal analysis
The thermal properties of the gelatin sponges were examined by a DuPont 2000
differential scanning calorimeter. Measurements were carried out under a nitrogen
atmosphere, using about 3–5 mg samples with a heating rate of 10±C/min up to
300±C.
In vitro degradation of gelatin sponges
In order to evaluate the amount of degraded gelatin, sponges (1 cm3) were immersed
in phosphate buffer solutions (0.01 M, 10 ml, pH 7.4) and incubated at 37±C in a
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constant-temperature shaking bath. Sodium azide was added to the released medium
to prevent microbial growth. At certain time intervals, 500 ¹l solutions were
withdrawn,  ltered through 0.45 ¹m Millipore  lters, and the amount of solubilized
gelatin was determined spectrophotometrically at ¸ D 660 nm by applying the
Lowry protein analysis method. Percent degradation values were calculated using
the following equation, %D D .mo ¡ mt=mo/ £ 100, where mo and mt are the
amounts (in g) of the initial and solubilized sponge, respectively.
Cytotoxicity analysis
The cytotoxicity of the gelatin sponges was tested in vitro by using the human
skin  broblast cell line HSAn2, which was obtained from the Animal Cell Culture
Collection (HUKUK, Ankara). The viability of the cells was measured by the
trypan blue dye exclusion method [39] and cell morphologies were monitored by
the Giemsa staining method. In brief, the procedure was as follows. Gelatin
sponges (10 of each type) in cube shapes .1 cm £ 1 cm £ 1 cm/ were weighed and
sterilized by UV application for 5.5 h prior to cell culture experiments. Fibroblast
cells [resuspended in Dulbecco’s modi ed Eagle’s medium and Ham’s F12 nutrient
mixture, 1 : 1 (DMEM/F12) supplemented with fetal calf serum (10%), gentamycin,
and vancomycin] were seeded into 24-well tissue culture plates (1 ml growth
medium in each well) at an initial density of 2 £ 104 cells / cm3 and incubated at
37±C in a humid (95–99%) atmosphere with 5% CO2. After 24 h, the medium
was replaced with fresh medium and sterilized sponge samples were added to the
wells. In the control plates, no sponge was added. After 48 h of incubation, the
total content of the medium was removed. Some plates were stained with Giemsa
and microphotographs were obtained under a light microscope in order to study
the morphological appearance of the cell monolayer. Viable cell numbers were
obtained as follows. Cells were dispersed with trypsin–EDTA solution, centrifuged,
resuspended in phosphate-buffered saline, stained with trypan blue dye, and counted
with a haemocytometer. Negative controls were also counted and compared with
others. The generation number of the cells (n) was calculated using the equation
n D .log CT ¡ log Co/= log 2, where CT is the number of living cells in the plate
and Co is the number of seeded cells. Doubling time (d) values were calculated
from the ratio t=n, where t is the duration of the experiment (chosen as 48 h) and
n is the generation number. Percent death values were calculated from the equation
% death D .Ccontrol ¡ Ctest=Ccontrol/ £ 100, where Ctest and Ccontrol are the average
total numbers of viable cells in the test and in the control plates, respectively, after
48 h of incubation. Cytotoxicities were recorded according to the numbers of viable
 broblast cells obtained by trypan blue exclusion.
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RESULTS AND DISCUSSION
Gelatin sponges
The use of gelatin in pharmaceutical and biomedical applications is particularly
attractive because of its biocompatibility and biodegradability, together with the
total absence of toxicity or allergic problems generally associated with the use of
synthetic polymers. Furthermore, gelatin is generally obtained from the collagenous
parts of tissues and is more convenient practically than collagen itself, because it has
no antigenicity while collagen expresses some under physiological conditions [40].
In this study, gelatin sponges were prepared at ambient temperature using rather
simple methods, avoiding the use of surfactants or organic solvents. The sponges
were white in color, very soft, porous, and had highly elastic structures (Fig. 2).
Sponge densities
The calculated average densities of all the sponges are given in Table 1. The
values obtained are quite low, which is expected since the structures were highly
porous. The density of the sponges prepared without any cross-linker (GS) was
found to be 0.0070 g/cm3. The addition of GA or EDAC cross-linkers changed this
value slightly, but no direct relationship between the amount of cross-linker and the
density was observed.
Thermal properties
Polymers which have hydrophilic components, such as hydroxyl or amide groups,
form intermolecular bonds in the presence of water and this strongly affects their
glass transition temperature. In certain proteins and polysaccharides, no glass
transition or melting is observed until decomposition of the main chain, because of
the high level of stabilization provided by the hydrogen bonding. The introduction
of small amounts of water may disrupt the intermolecular bonds, enhancing the
main chain motion. Two glass transition temperatures (Tg) were reported for gelatin
and this has been explained by the block copolymer nature of gelatin due to its
Figure 2. Gelatin sponge: (A) photograph and (B) SEM micrograph.
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amino acid content [41]. The  rst glass transition temperature is located around
90–100±C and corresponds to the association of the glass transition of ®-amino
acid blocks in the peptide chain. The second glass transition temperature is located
around 180–200±C, depending on the method of evaluation, and represents the
blocks of imino acids, proline and hydroxyproline, with glycine. It is assumed
that the latter Tg is responsible for the overall physical behavior of gelatin and is
the one most cited and studied. For dry gelatin samples, the Tg was reported to be
at 95±C by dilatometric [42], at 120±C by viscoelastic [43], and at 190±C by shear
modulus [44] measurements. For gelatin samples containing 9.6% moisture, the Tg
values were reported at ¡85±C, 130±C, and 180±C by measuring mechanical loss
properties [45]. There are also reports citing Tg values of 175±C and 180–200±C for
uncross-linked and cross-linked gelatins [41, 46, 47]. All of these values indicate
the complex structure of gelatin. In this study, the  rst Tg of the GS samples was
observed at 70±C (Fig. 3). For the GS-GA1 and GS-GA3 samples, this value shifted
to 77±C, giving an endothermic peak at 90±C, mainly as a result of cross-linking
with GA. With GS-GA1 and GS-GA3, a second endothermic peak was observed at
120±C and 125±C, respectively. This second endothermic absorption may be caused
by the removal of bound water (at 120±C or 125±C). Two endothermic absorption
peaks, at 222±C and 247±C, were observed for all samples. The one at 222±C may
be related to the conversion of reinforced rubbery structures to rubbery states and
the peak at 247±C could be the beginning of the degradation of gelatin structures.
Figure 3. DSC thermograms: (A) GS; (B) GS-GA1; (C) GS-GA3; (D) GS-EDAC4; and (E) GS-
EDAC6.
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Similar thermal behavior was observed for the samples cross-linked with EDAC
(Fig. 3). The  rst Tg , which corresponds to the movements of soft segments, shifted
from 70±C to 85±C and 65±C, giving endothermic peaks at 95±C and 80±C for GS-
EDAC4 and GS-EDAC6 samples, respectively. The endothermic peaks observed
with the same samples at 140±C and 130±C may be related to the removal of
bound water and the peaks observed around 220±C may be related to the conversion
of reinforced rubbery structures to rubbery states, similar to the GA cross-linked
samples.
For the GS-F and GS-EDAC1 samples, DSC thermographs were not obtained,
since these samples demonstrated very fast degradation (as fast as the uncross-
linked GS samples) in aqueous media.
Mechanical properties
The tensile strength and modulus of elasticity of the sponges are presented in Figs 4
and 5. GS samples (containing no cross-linker) had tensile strength and elastic
modulus values of 0.0135 MPa and 0.6451 MPa, respectively. The modulus of
elasticity increased signi cantly, up to 0.855 MPa .p < 0:001/, with an increase
in the amount of glutaraldehyde (Fig. 5). This is the result of the formation of
additional amide bonds with GA. On the other hand, the tensile strength values did
not demonstrate a signi cant change upon varying the amount of GA (0.0135 MPa,
p < 0:747).
The sponges cross-linked with EDAC demonstrated a different trend. As men-
tioned previously, carbodiimide helps bond formation between nitrogen and car-
Figure 4. Tensile strength values of the gelatin sponges.
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Figure 5. Modulus of elasticity values of the gelatin sponges.
bonyl residues of gelatin, but it does not remain in the structure. It was observed
that with an increase in the EDAC content, the tensile strength values decreased
from 0.0135 MPa to 0.0093 MPa .p < 0:0278/ (Fig. 4). The modulus of elasticity
values demonstrated  rst an increase and then a decrease. The highest value of the
modulus of elasticity was obtained for the GS-EDAC1 sample (0.8343 MPa). With
further addition of EDAC, the modulus of elasticity values decreased to 0.4500 MPa
.p < 0:0001/ (Fig. 5). These unexpected results could be explained by the plasti-
cizing effect of the residual free carbodiimide or eliminated substituted urea in the
sponge structures. For the fructose-containing gelatin sponges, modulus of elastic-
ity and tensile strength values of 0.659 MPa and 0.0114 MPa, respectively, were
obtained.
The mechanical properties of the gelatin sponges containing GA, EDAC or
fructose cross-linkers were found quite close to each other.
Degradation studies
The type and the amount of cross-linker used in the production of medical materials
are very important. Very low amounts of cross-linkers may cause rapid degradation,
while high amounts may be toxic. The extent of cross-linking determines the
stability of the biodegradable material and it can be evaluated by measuring the
time required for complete solubility. Although dissolved amounts of gelatin do
not give quantitative information about the extent of cross-linking at the molecular
level, reduced solubility can be accepted as an indication of the level of cross-
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Figure 6. Degradation curves of the GS and GS-F samples.
linking. Therefore, the amount of dissolved gelatin can be used in the quanti cation
of matrix degradation.
Percent degradation pro les of the gelatin sponges are given in Figs 6–8.
Depending on the type and the amount of cross-linker used, the time for complete
dissolution of the gelatin sponges varied from hours to days. For GS samples
(containing no cross-linker), high degradation rates were observed. Almost half
of each sponge was degraded within the  rst day and degradation was complete in
3.5 days (Fig. 6). The degradation rates of the GS-F samples (cross-linked with
fructose) were also quite high and they demonstrated a similar behavior to that of
GS samples (Fig. 6). For these samples, 30% of the sponge was degraded in 12 h
and degradation was complete in 4.5 days. This rapid degradation could be a result
of the high solubility of fructose in an aqueous medium, leading to rapid swelling
and rapid degradation.
For the GS-GA1 samples, 50% and 100% degradation was observed on the 18th
and 24th days, respectively. For the GS-GA3 samples, the same degradation pro le
was obtained on the 22nd and 28th days, respectively (Fig. 7). An increase in the
amount of glutaraldehyde, from 0.25 mmol to 0.50 mmol, slightly delayed complete
degradation from 24 days to 28 days.
Samples prepared with EDAC demonstrated very different degradation behav-
ior, depending on the amount of cross-linker (Fig. 8). GS-EDAC1 degraded com-
pletely in 4 days, showing that the covalent linkages produced by the addition of
0.026 mmol of EDAC were not strong enough for long-term stability. When the
amount of EDAC was increased, the sponges became more stable and the time re-
quired for complete degradation was longer. For the GS-EDAC4 and GS-EDAC6
samples, 10% degradation was observed on the seventh and tenth days, respectively.
After that period, an increase in the degradation rates was observed for both samples
and complete degradation was obtained on the 19th and 28th days, respectively.
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Figure 7. Degradation curves of the GA cross-linked samples.
Figure 8. Degradation curves of the EDAC cross-linked samples.
On the basis of these results, it can be concluded that the type and the amount of
cross-linker substantially affect the stability and it is possible to control the period
in which the gelatin sponges are stable by adding various amounts of cross-linking
agents, such as glutaraldehyde or carbodiimide.
Cytotoxicity
The potential source of cytotoxicity of a chemically cross-linked biomaterial may
be the residues of the unreacted cross-linking agent and/or the substances leaching
out as the matrix degrades. Cytotoxicity testing of chemical substances can be
accomplished by either in vivo or in vitro experiments. Nishi et al. reported that
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the results obtained in their in vitro experiments correlated well with those acquired
in in vivo experiments in the cytotoxicity testing of chemical substances [48]. The
cytotoxicity of a biomaterial can be evaluated in vitro by incubating the biomaterial
in the presence of suitable target cells. If the material is cytotoxic, the target cells
will be killed and the number of surviving cells will be inversely related to the
cytotoxicity. Quantitative evaluation of cell survival can be carried out counting the
cells after staining with trypan blue or by using the tetrazolium salt reduction assays
(MTT) [49, 50].
The British Standard BS5736 part 10 (method of test for toxicity to cells in culture
of extracts from medical devices) for dressing materials requires a rather simple
in vitro testing procedure. This involves soaking the dressing in a speci ed culture
medium for 24–72 h and then preparing a range of dilutions of this extract. One of
the three speci ed cell lines (or any other cell  tting certain criteria) is exposed to
the test agent for 24 h. The cells are then  xed, stained, and scored for survival on a
5-point scale, where 0, 1, 2, 3, and 4 stand for 0%, 0–25%, 25–50%, 50–75%, and
75–100% cell death, respectively. Although this method is not capable of detecting
growth-promoting or differentiating effects, it is designed as a fast screening method
of cytotoxicity [51].
In this study, the effects of different cross-linkers present in gelatin sponges on the
viability and morphology of  broblast cells were investigated in vitro. Cytotoxic
effects of the cross-linked gelatin sponges on a human skin  broblast cell line
(HSAn2) were tested by immersing the sponges in the culture medium. Although
this method is rather basic, the system allows the detection of toxicity, resulting from
direct leakage of degradation products from the materials and products produced by
the cell– sponge interactions.
The results for the cytotoxicity of the gelatin sponges are presented in Fig. 9 and
Table 2. All the sponges, except GS-GSA1, demonstrated some cytotoxicity at
varying degrees after 48 h of incubation with  broblasts. For the control group
(containing no sponge), the generation number (n), and doubling time were found
to be 1.9601 and 24.48 h, respectively; the cell morphologies are shown in Fig. 9A.
For the GS-containing plate, the value of n was found to be 0.8775, which is even
lower than that of the control group. This unexpected result can be explained by
the increase in viscosity of the feeding medium because of the fast degradation of
uncross-linked GS samples, so that the higher viscosity of the medium prevents
the diffusion of nutrients to the cells, causing a decrease in the number of viable
cells. On the other hand, the n values for the GS-F samples were found to be even
lower than those of the GS samples; this can be explained similarly to the diffusion
limitations created on the nutrients. By visual inspection and from the percent death
values, these two sponges were found to induce lower cell growth than the control
(Figs 9B and 9C).
The generation number for the GS-GA1-containing medium was very close to
the value of the control and the cells proliferated properly with normal morphology
(Fig. 9D). It is apparent that the amount of GA in the GS-GA1 sponges does not
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Figure 9. Microscopic examinationof the cells after 48 h of exposure to gelatin sponges. (A) Control
plate; (B) GS; (C) GS-F; (D) GS-GA1; (E) GS-GA3; (F) GS-EDAC1; (G) GS-EDAC4; (H) GS-
EDAC6.
Table 2.
Cytotoxicity results of the gelatin sponges
Sample Cross-linker (mmol) Generation No. (n) Doubling time (h) Death (%)
Control — 1.9601 24.48 —
GS — 0.8775 54.70 52.7
GS-GA1 0.25 1.9764 24.29 0
GS-GA3 0.50 0.2740 175.18 68.8
GS-EDAC1 0.026 0.5462 87.88 62.4
GS-EDAC4 0.26 0.5462 87.88 62.4
GS-EDAC6 1.30 0 — 91.8
GS-F 0.42 0.7395 64.91 57.0
affect the viability of  broblasts. However, when the GA content was increased
from 0.25 mmol to 0.50 mmol, a signi cant drop in n was observed, demonstrating
a moderate cytotoxic effect in GS-GA3 (Fig. 9E).
The effect of the amount of EDAC on the viability and morphology of the cells
can be seen in Figs 9F–9H. Similar n and percent growth values were obtained for
the GS-EDAC1- and GS-EDAC4-containing media. In the GS-EDAC6-containing
medium, mortality after 48 h was found to be 91.8%. Since no generation was
Cytotoxicity evaluation of gelatin sponges 1217
observed and the cell numbers were even lower than the initially added values, the
generation number was de ned as zero. The GS-EDAC6 samples demonstrated
a very high cytotoxic effect on cell cultures. In the literature, EDAC is reported
to be non-toxic, because it helps bond formation between the C and N groups of
gelatin and then leaves the structure by forming a urea derivative [1, 2]. It has
also been reported that collagen gels prepared by the incorporation of chondroitin-
6-sulfate (20%) enhanced the growth of keratinocytes but further treatment with
EDAC inhibited  broblast growth by 45% [52]. It has also been reported that
extensive cleaning and washing of carbodiimide-treated gels are needed to remove
the growth inhibitory effect of EDAC [53]. However, in this study, an extensive
cleaning process did not apply to the prepared sponges, since they take highly
hydrated, soft jelly-like forms and lose their spongy forms upon washing. Since the
washing process could not be carried out, it is quite possible that urea derivatives
remained in the structure and caused toxicity. The amount of cross-linker in the
GS-GA1 and GS-EDAC4 samples was almost the same, but the viability of the
cells and the cell morphologies in GS-GA1 were much better than those of the GS-
EDAC4-containing medium. The important point is the amount of cross-linker that
reacts with gelatin. It can be concluded that GA is more reactive than EDAC, so that
even when similar amounts of GA and EDAC were added to the gelatin solutions
(as in the GS-GA1 and GS-EDAC4 samples), more GA would go into the sponge
structure by forming cross-links. Secondly, urea derivatives of EDAC might stay
in the porous structure after the cross-linking reaction and might diffuse into the
culture medium, causing inhibition of cell growth. Therefore, in the preparation
of sponge forms of gelatin where further washing could not been carried out, GA
can be considered a more suitable cross-linker than EDAC. The results obtained in
this study show that the cytotoxicity of gelatin sponges depends on the type and the
amount of cross-linker agent and the cross-linking process.
CONCLUSION
The effects of different cross-linkers used in the preparation of gelatin sponges on
the viability of  broblast cells were investigated in in vitro systems. Glutaraldehyde
was found to be a better cross-linker than EDAC when used at a low concentration,
because GA cross-linked sponges demonstrated a better cell morphology and a
higher cell viability than those of the EDAC cross-linked ones. These samples have
great potential for various applications in biomedicine, such as wound dressings or
tissue engineering scaffolds.
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